Evidence map›Paper›PMID 41367771›Full record

ArticleQuantitative imaging in medicine and surgery2025

Exploring the evolving landscape of radiomics in lung cancer: a comprehensive bibliometric analysis [2008-2024].

Xing Tang, Guoyan Bai, Qing Zhang, Jing Shen, Jianlin Wu

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xing Tang *Department of Radiology, Zhongshan Hospital Affiliated of Dalian University, Dalian, China.
Guoyan Bai *Department of Clinical Laboratory, Shaanxi Provincial People's Hospital, Xi'an, China.
Qing ZhangDepartment of Radiology, Zhongshan Hospital Affiliated of Dalian University, Dalian, China.
Jing ShenDepartment of Radiology, Zhongshan Hospital Affiliated of Dalian University, Dalian, China.
Jianlin WuDepartment of Radiology, Zhongshan Hospital Affiliated of Dalian University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Radiomics in lung cancer represents a transformative advancement in oncology, utilizing high-dimensional data from medical imaging to enhance diagnosis, prognosis, and treatment prediction. In this study, we conducted a bibliometric analysis to explore the research landscape and frontier trends of radiomics in lung cancer. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection (WoSCC) to gather literature about "radiomics in lung cancer" from 2008 to 2024. Bibliometric analysis and data visualization were conducted using VOSviewer, CiteSpace, and the R package "Bibliometrix". Results: A total of 1,324 articles were analyzed. China led in productivity with 622 publications, whereas the University of Texas System was the top contributing institution with 163 publications. Conclusions: This bibliometric study highlights radiomics' growing impact on lung cancer research, emphasizing diagnostic imaging, and personalized medicine. Future research should center on standardizing methodologies and prediction models, and integrating multi-modal data to enhance diagnostics, treatment planning, and personalized care.

Indexed as

bibliometric analysisimaging biomarkerslung cancerRadiomics

Identifiers

PMID41367771
PMCPMC12682534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.